XETRA EUR

Formycon AG (FYB.DE)

18.88 -0.22 (-1.15%)

At close: October 30 at 5:35:27 PM GMT+1

Formycon AG (WBO:FYB) (Q2 2026) Earnings Call Highlights: Revenue Nearly Triples on Strong ...

GuruFocus.com 2mo ago

FYB.DE
-1.15%
FYB.VI
Formycon AG (WBO:FYB) Q1 2026 Earnings Call Highlights: Doubling Revenue and Strategic ...

GuruFocus.com 5mo ago

FYB.DE
-1.15%
FYB.VI
Downgrade: Here's How Analysts See Formycon AG (ETR:FYB) Performing In The Near Term

Simply Wall St. 6mo ago

FYB.DE
-1.15%
Formycon AG (XTER:FYB) Full Year 2025 Earnings Call Highlights: Transformational Year with ...

GuruFocus.com 6mo ago

FYB.DE
-1.15%
Formycon Invites to Conference Call on the Results of the Financial Year 2025 and Announces Participation in International Investor Conferences in the 2nd Quarter of 2026

NewMediaWire 6mo ago

FYB.DE
-1.15%
Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by USFDA

PR Newswire 19d ago

ZYDUSLIFE.NS

FYB.DE
-1.15%
Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by USFDA

CNW Group 19d ago

ZYDUSLIFE.NS

FYB.DE
-1.15%
European Growth Companies With High Insider Ownership For June 2026

Simply Wall St. 4mo ago

KURN.SW

CDR.WA

VGO.WA
European Growth Leaders With High Insider Ownership

Simply Wall St. 5mo ago

NWRN.SW

CL=F

KEBNI-B.ST
Formycon AG and OneSource Specialty Pharma Announce Strategic Manufacturing Partnership for Biosimilars

NewMediaWire 3mo ago

FYB.DE
-1.15%
ONESOURCE.BO
February 2026's European Stocks Possibly Priced Below Estimated Value

Simply Wall St. 8mo ago

BEER.HE

FYB.DE
-1.15%
NBITF

U.S. markets closed

Formycon AG (FYB.DE)

Formycon AG (WBO:FYB) (Q2 2026) Earnings Call Highlights: Revenue Nearly Triples on Strong ...

Formycon AG (WBO:FYB) Q1 2026 Earnings Call Highlights: Doubling Revenue and Strategic ...

Downgrade: Here's How Analysts See Formycon AG (ETR:FYB) Performing In The Near Term

Formycon AG (XTER:FYB) Full Year 2025 Earnings Call Highlights: Transformational Year with ...

Formycon Invites to Conference Call on the Results of the Financial Year 2025 and Announces Participation in International Investor Conferences in the 2nd Quarter of 2026

Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by USFDA

Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by USFDA

European Growth Companies With High Insider Ownership For June 2026

European Growth Leaders With High Insider Ownership

Formycon AG and OneSource Specialty Pharma Announce Strategic Manufacturing Partnership for Biosimilars

February 2026's European Stocks Possibly Priced Below Estimated Value